Halozyme Therapeutics (HALO) Tops Q2 EPS by 15c ; Offers Guidance

Go back to Halozyme Therapeutics (HALO) Tops Q2 EPS by 15c ; Offers Guidance
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 111.92 +2.24 (2.04%)
Previous Close $109.68    52 Week High $18.39 
Open $109.72    52 Week Low $6.96 
Day High $112.05    P/E N/A 
Day Low $109.38    EPS $-0.58 
Volume 7,481,339